Antonius Stegmann - Mymetics Corp Head BV

All Insiders . USA . 
Stock . Mymetics Corp . Stakeholders . Insider . Antonius Stegmann
MYMX Stock  USD 0  0.00  0.00%   

Insider

Antonius Stegmann is Head BV of Mymetics Corp
Phone41 21 653 4535
Webhttps://www.mymetics.com

Mymetics Corp Management Efficiency

The company has return on total asset (ROA) of (0.1382) % which means that it has lost $0.1382 on every $100 spent on assets. This is way below average. Mymetics Corp's management efficiency ratios could be used to measure how well Mymetics Corp manages its routine affairs as well as how well it operates its assets and liabilities.
Mymetics Corp currently holds 162 K in liabilities. Mymetics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mymetics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Mymetics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mymetics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mymetics to invest in growth at high rates of return. When we think about Mymetics Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Timothy PigotAerovate Therapeutics
53
Andreas EMBAMolecular Partners AG
58
Michael PitznerMolecular Partners AG
N/A
John CPAMediciNova
N/A
Timothy MBAAerovate Therapeutics
62
Annick DeschoolmeesterPharvaris BV
51
Deepika PharmDPmv Pharmaceuticals
48
Michael GaitPepGen
N/A
Winston MBAPmv Pharmaceuticals
48
CPA MBAPharvaris BV
63
Guizhong LiuAdagene
53
Seth LewisMolecular Partners AG
N/A
Maryann CiminoPharvaris BV
N/A
Patrick AmstutzMolecular Partners AG
49
Scott AndersonAnebulo Pharmaceuticals
N/A
Man MBAAdagene
47
Jochen KnollePharvaris BV
74
Anne LesagePharvaris BV
63
Niels SvenstrupPepGen
54
Jason CPAMediciNova
46
Hing WongHCW Biologics
70
Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland. Mymetics Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people. Mymetics Corp [MYMX] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Asset-0.14

Mymetics Corp Leadership Team

Elected by the shareholders, the Mymetics Corp's board of directors comprises two types of representatives: Mymetics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mymetics. The board's role is to monitor Mymetics Corp's management team and ensure that shareholders' interests are well served. Mymetics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mymetics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sylvain Fleury, Chief Officer
Mario Amacker, Head Manufacturing
Ronald Kempers, CEO and President and CFO
Antonius Stegmann, Head BV

Mymetics Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Mymetics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-0.14
Operating Margin(1.76) %
Current Valuation83.16 M
Shares Outstanding303.76 M
Shares Owned By Insiders54.90 %
Price To Earning(2.40) X
Price To Sales12.17 X
Revenue3 K
Gross Profit(545 K)
EBITDA(1.96 M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft

Additional Tools for Mymetics Pink Sheet Analysis

When running Mymetics Corp's price analysis, check to measure Mymetics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mymetics Corp is operating at the current time. Most of Mymetics Corp's value examination focuses on studying past and present price action to predict the probability of Mymetics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mymetics Corp's price. Additionally, you may evaluate how the addition of Mymetics Corp to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY